MATERIALS AND METHODS: Thirty-two Wistar rats were divided into four groups. The
rats in Group 1 received melatonin and underwent radiation therapy. The rats in
Group 2 received no melatonin and underwent radiation therapy. The rats in Group
3 received melatonin and underwent sham radiation therapy. The rats in Group 4
received no melatonin and underwent sham radiation therapy. Melatonin was
administered at a dose of 100 mg/kg using an intraperitoneal injection. Radiation
therapy was delivered on a Cobalt-60 unit using a single fraction of 18 Gy
through an anterior portal covering the right lung in entirety. The rats
underwent euthanasia at 6 weeks following radiation therapy. The lungs were
dissected and blinded histopathological evaluation was performed.
RESULTS: Concerning the right lung, a decrease in intra-alveolar edema and
intra-alveolar erythrocytes was observed despite an increase in activated
macrophages, intra-alveolar fibrosis, hyaline arteriosclerosis and alveolar wall
thickness for the rats in Group 1 as compared to the rats in Group 2. Concerning
the left lung, a decrease in alveolar neutrophils and intra-alveolar erythrocytes
was evident despite an increase in activated macrophages, hyaline
arteriosclerosis and alveolar wall thickness for the rats in Group 1 as compared
to the rats in Group 2.
CONCLUSIONS: This study puts forward the histopathological evidence regarding the
effectiveness of melatonin as a protectant against acute lung injury induced by
radiation therapy through restrained inflammation, regrettably at the expense of
promoted fibrosis. The effectiveness of melatonin as a protectant against acute
lung injury induced by radiation therapy needs to be evaluated further for the
unresolved concerns regarding the safety.